Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Pancreas Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03806309
What this trial is testing

OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC

Who this might be right for
Pancreatic Ductal AdenocarcinomaLocally Advanced CancerMetastatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 106
Testing effectiveness (Phase 2)Ended earlyNCT00881621
What this trial is testing

Lapatinib and Capecitabine for Second Line Treatment of Pancreas Cancer

Who this might be right for
Pancreas Cancer
Georgetown University 17
Testing effectiveness (Phase 2)Looking for participantsNCT06244771
What this trial is testing

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Who this might be right for
Advanced Solid Tumors With KRAS G12C MutationsSolid Tumor, AdultUnresectable Solid Tumor+5 more
Frontier Medicines Corporation 403
Large-scale testing (Phase 3)Study completedNCT02395016
What this trial is testing

Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Biotech Pharmaceutical Co., Ltd. 90
Large-scale testing (Phase 3)Looking for participantsNCT03257033
What this trial is testing

Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

Who this might be right for
Locally Advanced Pancreatic Cancer
RenovoRx 190
Early research (Phase 1)Study completedNCT00544193
What this trial is testing

Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
City of Hope Medical Center 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07683221
What this trial is testing

SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Shandong Cancer Hospital and Institute 47
Early research (Phase 1)Study completedNCT04925284
What this trial is testing

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

Who this might be right for
Non Small Cell Lung CancerCervical CancerSCCHN+8 more
Exelixis 269
Early research (Phase 1)Study completedNCT01294358
What this trial is testing

Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial

Who this might be right for
Histologically or Cytologically Confirmed Pancreatic CaUnresectable or Borderline Resectable Pancreatic Ca
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Study completedNCT02565641
What this trial is testing

Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Hoffmann-La Roche 63
Testing effectiveness (Phase 2)Study completedNCT00338039
What this trial is testing

Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 69
Testing effectiveness (Phase 2)Study completedNCT01821729
What this trial is testing

Radiation w/FOLFIRINOX-Losartan for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 50
Large-scale testing (Phase 3)Study completedNCT01827553
What this trial is testing

Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy

Who this might be right for
Pancreatic Cancer
University of Erlangen-Nürnberg Medical School 830
Testing effectiveness (Phase 2)Looking for participantsNCT07575191
What this trial is testing

Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Smartwise Sweden AB 9
Testing effectiveness (Phase 2)Study completedNCT00114179
What this trial is testing

Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the PancreasStage II Pancreatic CancerStage III Pancreatic Cancer
National Cancer Institute (NCI) 82
Not applicableLooking for participantsNCT05524090
What this trial is testing

PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerLocally Advanced Pancreatic AdenocarcinomaPancreatic Adenocarcinoma Non-resectable+1 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 223
Large-scale testing (Phase 3)Study completedNCT00024427
What this trial is testing

Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganPancreatic Cancer
Wellstat Therapeutics 250
Testing effectiveness (Phase 2)Study completedNCT03138720
What this trial is testing

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

Who this might be right for
Resectable Pancreatic CancerUnresectable Pancreatic CancerPancreatic Adenocarcinoma+1 more
HonorHealth Research Institute 40
Testing effectiveness (Phase 2)Study completedNCT03767582
What this trial is testing

Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.

Who this might be right for
Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Ductal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Large-scale testing (Phase 3)Study completedNCT00471146
What this trial is testing

Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

Who this might be right for
Carcinoma, Pancreatic Ductal
Pfizer 630
Next Page